Literature DB >> 11843281

Successful unrelated bone marrow transplantation after arsenic trioxide treatment in a patient with relapsed acute promyelocytic leukemia.

Michiaki Mikoshiba, Kazuteru Ohashi, Naoko Takei, Yoshiki Okuyama, Yasuharu Maeda, Kiyoshi Hiruma, Hideki Akiyama, Osamu Fukuhara, Akihiro Takeshita, Hisashi Sakamaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11843281     DOI： 10.1007/bf02981989

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  12 in total

1.  All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG).

Authors:  N Asou; K Adachi; J Tamura; A Kanamaru; S Kageyama; A Hiraoka; E Omoto; H Sakamaki; K Tsubaki; K Saito; R Ohno
Journal:  Cancer Chemother Pharmacol       Date:  1997       Impact factor: 3.333

2.  Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemia.

Authors:  S Galimberti; F Papineschi; A Carmignani; R Testi; R Fazzi; M Petrini
Journal:  Bone Marrow Transplant       Date:  1999-08       Impact factor: 5.483

3.  Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid.

Authors:  T Tobita; A Takeshita; K Kitamura; K Ohnishi; M Yanagi; A Hiraoka; T Karasuno; M Takeuchi; S Miyawaki; R Ueda; T Naoe; R Ohno
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

4.  Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients.

Authors:  C Niu; H Yan; T Yu; H P Sun; J X Liu; X S Li; W Wu; F Q Zhang; Y Chen; L Zhou; J M Li; X Y Zeng; R R Yang; M M Yuan; M Y Ren; F Y Gu; Q Cao; B W Gu; X Y Su; G Q Chen; S M Xiong; T D Zhang; S Waxman; Z Y Wang; Z Chen; J Hu; Z X Shen; S J Chen
Journal:  Blood       Date:  1999-11-15       Impact factor: 22.113

5.  The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation.

Authors:  K Ohashi; J Tanabe; R Watanabe; T Tanaka; H Sakamaki; A Maruta; S Okamoto; N Aotsuka; K Saito; M Nishimura; H Oh; M Matsuzaki; S Takahashi; S Yonekura
Journal:  Am J Hematol       Date:  2000-05       Impact factor: 10.047

Review 6.  Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia.

Authors:  S L Soignet
Journal:  Oncologist       Date:  2001

7.  Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.

Authors:  G Q Chen; X G Shi; W Tang; S M Xiong; J Zhu; X Cai; Z G Han; J H Ni; G Y Shi; P M Jia; M M Liu; K L He; C Niu; J Ma; P Zhang; T D Zhang; P Paul; T Naoe; K Kitamura; W Miller; S Waxman; Z Y Wang; H de The; S J Chen; Z Chen
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

8.  Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia.

Authors:  S Y Huang; C S Chang; J L Tang; H F Tien; T L Kuo; S F Huang; Y T Yao; W C Chou; C Y Chung; C H Wang; M C Shen; Y C Chen
Journal:  Br J Haematol       Date:  1998-12       Impact factor: 6.998

9.  Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.

Authors:  S L Soignet; P Maslak; Z G Wang; S Jhanwar; E Calleja; L J Dardashti; D Corso; A DeBlasio; J Gabrilove; D A Scheinberg; P P Pandolfi; R P Warrell
Journal:  N Engl J Med       Date:  1998-11-05       Impact factor: 91.245

Review 10.  Differentiation therapy of leukemia: achievements, limitations and future prospects.

Authors:  M Hozumi
Journal:  Int J Hematol       Date:  1998-08       Impact factor: 2.490
View more
  1 in total

1.  Delayed hematological recovery following autologous transplantation utilizing peripheral blood stem cells harvested after treatment with arsenic trioxide.

Authors:  Toshimitsu Ueki; Kazuteru Ohashi; Minako Jinta; Yoshiki Okuyama; Kiyoshi Hiruma; Hideki Akiyama; Hisashi Sakamaki
Journal:  Pathol Oncol Res       Date:  2008-06-14       Impact factor: 3.201
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.